Search Results for: GENE
The UN sees food prices staying high for years.That not only undermines much of the global economy, it means a great many people don’t eat at all. The UN’s solutions are to kill bio-fuel...
Published:
Fulgent Genetics expects to offer more than 4 million shares in an expected price range of $12 to $14 per share in an initial public offering valued up to about $74 million.
Published:
Last Updated:
Goldman Sachs has upgraded its outlook for Myriad Genetics to Buy.
Published:
Targeted Genetics (TGEN) is doing something unbelievable today. The company posted actual earning this morning when it was supposed to lose money according the entire large coverage universe of...
Published:
Morgan Stanley has downgraded its outlook for Seagen to Equal Weight.
Published:
BMO Capital has downgraded its outlook for Seagen to Market Perform.
Published:
It is rare for a person who has reached the status of billionaire to ever lose it — but it is not unheard of. Occasionally, however, someone who was at one time worth billions sees their net...
Published:
Source: ThinkstockToday’s report from the Conference Board on consumer confidence was disappointing, to say the least. As we noted, it may not be a shock to many observers, but consumer confidence...
Published:
Last Updated:
Earlier this year, China’s prime minister said the country’s GDP would be up 8% in 2009. He used the forum for making the prediction as an opportunity to press the advantage of his economic...
Published:
Last Updated:
From BioHealth Investor Shares of Targeted Genetics (TGEN) jumped more than 52% on Monday, ending the trading day at $5.87 a share. Over 7 million shares traded hands, which is 6900% over the 3-month...
Published:
For some reason, the huge trade gap announcement did not stir much concern in Congress about the value of the yuan. The figure rose to $42.3 billion in May. Instead of focusing on the 12.1% increase...
Published:
On Monday, NRG Energy (NYSE:NRG) management rejected an unsolicited buyout offer from Exelon (NYSE:EXC) that would have exchanged one share of NRG for 0.485 shares of Exelon. Exelon probably didn’t...
Published:
Last Updated:
Shares of Genetic Technologies practically doubled in Tuesday's session after the company announced the signing of an exclusive worldwide license agreement with the University of Melbourne.
Published:
Last Updated:
Genzyme Corp. (NASDAQ: GENZ) has taken steps to remedy its situation with the FDA and to remedy its image. Genzyme issued some new guidance with an investor update and said it would discard the...
Published:
Perhaps it is the time of year or just the general run up in the market, but the number of online promotions for penny stock services is flourishing. One particularly exciting promotion comes from...
Published: